We are pleased to announce that Dr. Jörg Taubel, CEO of Richmond Pharmacology, will be attending the Hypertension 2024 Scientific Sessions from 5th to 8th September in Chicago, Illinois.

This event, hosted by the American Heart Association, brings together leading experts to discuss the latest research and advancements in hypertension.

The conference features oral and poster presentations, panel discussions, and sessions tailored for clinicians, researchers, and primary care providers.

To connect with Dr. Taubel during the event, please reach out to arrange a meeting.

Tofind out more, click here.

Latest news

How Richmond Pharmacology Supports Sponsors Navigating ICH E6 (R3)

February 5, 2026
The updated ICH E6 (R3) guideline places greater emphasis on proportionality, risk-based oversight...
Read more

Events

Clinical Trials Innovation Programme

10 - 11 February 2026
Richmond Pharmacology is pleased to attend the Clinical Trials Innovation Programme Conference in Nice, France, 10–11 February 2026.
View event